Külli Kingo

10.8k total citations · 1 hit paper
99 papers, 3.5k citations indexed

About

Külli Kingo is a scholar working on Immunology, Dermatology and Cell Biology. According to data from OpenAlex, Külli Kingo has authored 99 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Immunology, 46 papers in Dermatology and 27 papers in Cell Biology. Recurrent topics in Külli Kingo's work include Psoriasis: Treatment and Pathogenesis (45 papers), Dermatology and Skin Diseases (40 papers) and melanin and skin pigmentation (21 papers). Külli Kingo is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (45 papers), Dermatology and Skin Diseases (40 papers) and melanin and skin pigmentation (21 papers). Külli Kingo collaborates with scholars based in Estonia, Germany and Switzerland. Külli Kingo's co-authors include Sulev Kõks, Helgi Silm, Eero Vasar, Andrew Blauvelt, Maire Karelson, Diamant Thaçi, Kristian Reich, Ranno Rätsep, Andreas Pinter and Tsen‐Fang Tsai and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Külli Kingo

96 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial

2015 429 citations Külli Kingo et al. profile →

Peers

Countries citing papers authored by Külli Kingo

Since Specialization

Citations

This map shows the geographic impact of Külli Kingo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Külli Kingo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Külli Kingo more than expected).

Fields of papers citing papers by Külli Kingo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Külli Kingo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Külli Kingo. The network helps show where Külli Kingo may publish in the future.

Co-authorship network of co-authors of Külli Kingo

This figure shows the co-authorship network connecting the top 25 collaborators of Külli Kingo. A scholar is included among the top collaborators of Külli Kingo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Külli Kingo. Külli Kingo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-World Clinical, Psychosocial, and Economic Burden of Atopic Dermatitis: Results From the ESSENTIAL AD Multicountry Study 2024 ·Dermatology and Therapy ·Spyridon Gkalpakiotis, (unknown), Külli Kingo, (unknown), (unknown), Aleksandra Lesiak, Alin Codruț Nicolescu, Razvigor Darlenski, (unknown), (unknown), (unknown), (unknown), (unknown)	2
2	Polymorphisms in corticotrophin‐releasing hormone–proopiomalanocortin (CRH–POMC) system genes: Neuroimmune contributions to psoriasis disease 2023 ·Journal of the European Academy of Dermatology and Venereology ·(unknown), Ranno Rätsep, Tanel Traks, (unknown), Darya Gaysina, Külli Kingo, Sulev Kõks	3
3	Genome-wide meta-analysis identifies novel loci conferring risk of acne vulgaris 2023 ·European Journal of Human Genetics ·Maris Teder‐Laving, Mart Kals, Anu Reigo, (unknown), (unknown), Mariliis Vaht, Tiit Nikopensius, Andres Metspalu, Külli Kingo	11
4	Skin Colonization with S. aureus Can Lead to Increased NLRP1 Inflammasome Activation in Patients with Atopic Dermatitis 2023 ·Journal of Investigative Dermatology ·(unknown), (unknown), (unknown), Martin Pook, (unknown), (unknown), Anu Remm, Tanel Tenson, Kaur Alasoo, Ulrich Mrowietz, Stephan Weidinger, Külli Kingo, Ana Rebane	17
5	Epigenetic quantification of immunosenescent CD8⁺ TEMRA cells in human blood 2022 ·Aging Cell ·(unknown), Liina Tserel, Pauliina Rumm, (unknown), Külli Kingo, Kai Saks, (unknown), Raivo Uibo, Riin Tamm, Hedi Peterson, Kai Kisand, Pärt Peterson	38
6	Olfactomedin-4 improves cutaneous wound healing by promoting skin cell proliferation and migration through POU5F1/OCT4 and ESR1 signalling cascades 2022 ·Cellular and Molecular Life Sciences ·Mariliis Klaas, (unknown), (unknown), (unknown), (unknown), (unknown), Külli Kingo, Esko Kankuri, Viljar Jaks	9
7	miRNA expression profiles of the perilesional skin of atopic dermatitis and psoriasis patients are highly similar 2022 ·Scientific Reports ·Gemma Carreras‐Badosa, Julia Maslovskaja, (unknown), (unknown), Tarmo Annilo, Freddy Lättekivi, Matthias Hübenthal, Elke Rodríguez, Stephan Weidinger, Külli Kingo, Ana Rebane	12
8	The Expression Pattern of Genes Related to Melanogenesis and Endogenous Opioids in Psoriasis 2021 ·International Journal of Molecular Sciences ·(unknown), (unknown), Ene Reimann, Paula Reemann, Ele Prans, Tanel Traks, Eero Vasar, Helgi Silm, Külli Kingo, Sulev Kõks	6
9	Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis: A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III Study 2021 ·BioDrugs ·Steven R. Feldman, (unknown), Grażyna Pulka, Külli Kingo, (unknown), Fausto Berti, (unknown), (unknown), Eric Guenzi, (unknown), (unknown), Richard Kay, (unknown)	22
10	Monocytes present age‐related changes in phospholipid concentration and decreased energy metabolism 2020 ·Aging Cell ·Mario Saare, Liina Tserel, Liis Haljasmägi, (unknown), (unknown), Margus Eimre, (unknown), Külli Kingo, Kai Saks, Riin Tamm, Lili Milani, Kai Kisand, Pärt Peterson	43
11	Looking beyond the brain to improve the pathogenic understanding of Parkinson’s disease: implications of whole transcriptome profiling of Patients’ skin 2017 ·BMC Neurology ·Anu Planken, (unknown), Ene Reimann, Liis Kadastik‐Eerme, Külli Kingo, Sulev Kõks, Pille Taba	33
12	Psoriasis-Specific RNA Isoforms Identified by RNA-Seq Analysis of 173,446 Transcripts 2016 ·Frontiers in Medicine ·Sulev Kõks, (unknown), Ene Reimann, Ele Prans, Kristi Abram, Helgi Silm, Gea Kõks, Külli Kingo	25
13	Quality of Life and Emotional State in Chronic Skin Disease 2015 ·Acta Dermato Venereologica ·(unknown), Anu Aluoja, Külli Kingo	59
14	MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes 2014 ·Journal of Allergy and Clinical Immunology ·Ana Rebane, Toomas Runnel, Alar Aab, Julia Maslovskaja, Beate Rückert, Maya Zimmermann, Mario Plaas, Jaanika Kärner, Angela Treis, Maire Pihlap, Uku Haljasorg, Helen Hermann, Nikoletta Nagy, Lajos Kemény, (unknown), Külli Kingo, Mei Li, Mark Boldin, Cezmi A. Akdiş	161
15	MicroRNA-155 is Dysregulated in the Skin of Patients with Vitiligo and Inhibits Melanogenesis-associated Genes in Melanocytes and Keratinocytes 2014 ·Acta Dermato Venereologica ·(unknown), Stoyan Tankov, Ele Prans, Alar Aab, Helen Hermann, Paula Reemann, Maire Pihlap, Maire Karelson, Kristi Abram, Kai Kisand, Külli Kingo, Ana Rebane	55
16	Quality of Life and Emotional State in Vitiligo in an Estonian Sample: Comparison with Psoriasis and Healthy Controls 2013 ·Acta Dermato Venereologica ·Maire Karelson, Helgi Silm, Külli Kingo	71
17	Antioxidants have possible therapeutic activity for psoriasis 2011 ·Murdoch Research Repository (Murdoch University) ·Ursel Soomets, Külli Kingo, Riina Mahlapuu, Sulev Kõks	1
18	Polymorphisms in the interleukin-10 gene cluster are possibly involved in the increased risk for major depressive disorder 2008 ·BMC Medical Genetics ·Tanel Traks, Kati Koido, Triin Eller, Eduard Maron, Külli Kingo, Veiko Vasar, Eero Vasar, Sulev Kõks	30
19	Possible relations between the polymorphisms of the cytokines IL-19, IL-20 and IL-24 and plaque-type psoriasis 2005 ·Genes and Immunity ·Sulev Kõks, Külli Kingo, (unknown), Ranno Rätsep, Maire Karelson, Helgi Silm, Eero Vasar	58
20	IL-10 promoter polymorphisms influence disease severity and course in psoriasis 2003 ·Genes and Immunity ·Külli Kingo, Sulev Kõks, Helgi Silm, Eero Vasar	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact